Browsing: Wegovy
Gallup released a survey this week showing that the obesity rate among US adults has fallen to 37% this year, a significant…
Injectable glucagon-like peptide-1 agonists, or GLP-1s, were first approved as diabetes medications 20 years ago. They’ve since become popular as…
You may have heard of “Ozempic mouth”, “Ozempic tongue” and “Ozempic penis.” Well, here’s yet another “O” body part term…
California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss. Other states are…
Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. In fact, about 1 in 8 Americans have taken…
When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge Lund,…
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
You may have heard of “Ozempic face”, “Ozempic butt” and “Ozempic finger,” three things that I have written about previously…
In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the…
A commercial airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the…